Inventor · disambiguated record
Chin-Chun Lu
Also filed as: LU CHIN-CHUN · LU CHIN-CHUN JEAN
15 granted patents·3 pending applications·91 citations·filing 1994–2022
92Inventor score
Files withMERCK & CO INC9SIBIA NEUROSCIENCES INC3CELGENE CORP2FATE THERAPEUTICS INC2HANGZHOU GLUBIO PHARMACEUTICAL CO LTD2
Top patents by PatentIndex Score
18 records- 0172US5849895AHuman N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses thereforSIBIA NEUROSCIENCES INC·Filed 1994·Granted Dec 15, 1998·19 cites·25 claims
- 0270US5985586AMethods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptorsSIBIA NEUROSCIENCES INC·Filed 1995·Granted Nov 16, 1999·18 cites·4 claims
- 0370US5912122ANucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6SIBIA NEUROSCIENCES INC·Filed 1995·Granted Jun 15, 1999·24 cites·12 claims
- 0468US12486281B2Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Granted Dec 2, 2025·0 cites·25 claims
- 0561US6956102B2Human N-methyl-D-aspartate receptor subunits nucleic acids encoding same and uses thereforMERCK & CO INC·Filed 2001·Granted Oct 18, 2005·1 cites·2 claims
- 0661US6864358B2Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses thereforMERCK & CO INC·Filed 2001·Granted Mar 8, 2005·1 cites·3 claims
- 0761US6825322B2Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses thereforMERCK & CO INC·Filed 2002·Granted Nov 30, 2004·1 cites·3 claims
- 0861US6469142B1Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses thereforMERCK & CO INC·Filed 2000·Granted Oct 22, 2002·1 cites·3 claims
- 0961US6316611B1Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses thereforMERCK & CO INC·Filed 1997·Granted Nov 13, 2001·12 cites·23 claims
- 1059US11306101B2Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2020·Granted Apr 19, 2022·0 cites·35 claims
- 1154US2025049798A1Wee1 protein kinase degradation agent and use thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1254US2024360150A1Isoindolinone compounds and uses thereofHANGZHOU GLUBIO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1349US6521413B1Human N-methyl-D-aspartate receptor subnits, nucleic acids encoding same and uses thereforMERCK & CO INC·Filed 1999·Granted Feb 18, 2003·6 cites·65 claims
- 1448US2015126507A1Compounds to treat hearing lossFATE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1547US6362316B1Human metabotropic glutamate receptor subtype mGluR6 proteinMERCK & CO INC·Filed 1999·Granted Mar 26, 2002·5 cites·8 claims
- 1638US9370510B2Small molecule compounds to treat hearing lossFATE THERAPEUTICS INC·Filed 2013·Granted Jun 21, 2016·0 cites·22 claims
- 1737US6111091AHuman N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses thereforeMERCK & CO INC·Filed 1997·Granted Aug 29, 2000·2 cites·12 claims
- 1833US6376660B1Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses thereforMERCK & CO INC·Filed 1997·Granted Apr 23, 2002·1 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Chin-Chun Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →